Twitter Linkedin-in

Immuno Series UK: Virtual

: Advances in Immuno-Oncology

Advances in Immuno-Oncology

24 - 25 August 2020 | BST (UTC+1)
Book Now

Immuno Series UK: Virtual has now concluded. Registered delegates have access to the platform until 4th September 2020. Please click here to be directed to the website for our in-person event, Immuno Series UK, taking place 18 - 19 May 2021.

5th Annual
Advances in Immuno-Oncology Congress24 - 25 August 2020 | BST (UTC+1)

An outstanding and comprehensive programme showcasing the key therapeutic strategies and technological advances impacting this marketplace

Download Agenda
Register

The Advances in Immuno-Oncology Congress includes...

Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools

Over 60 presentations, case studies and panel discussions focussed on the key opportunities and challenges in immuno-oncology, from therapeutic strategies and biomarker development through to clinical research

PLUS interactive opportunities including:

  • Workshop on Accelerating the Treatment & Response Rate of Cancer Immunotherapies
  • 6 roundtable discussions on key industry growth areas within immuno-oncology

Agenda at a Glance

Day One 

  • Discovery of Immuno-Oncology Therapies: Inhibitory Pathway & Cell-Based Approaches
  • Translational Immuno-Oncology
  • Personalised Therapies for Immuno-Oncology

Day Two

  • Discovery of Immuno-Oncology Therapies: Antibody and Virus-Based Approaches
  • Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
  • Clinical Research & Trials in Immuno- Oncology
Content Hub Graphic Carousel
Oxford Global Content HUB
Access complementary resources including Webinars, Q&A Sessions, Newsletters and much more.
Immuno Key Image Carousel
Immuno Series UK
Immuno Series UK, taking place in London UK, May 2021
Carousel
Upcoming Live Webinar
Upcoming Webinar from Personalis' Robert Power on Enabling the Expansive Interrogation of a Tumour and its Micro-environment from a Single Sample for all Precision Oncology Biomarker Discovery Applications
Q&A
Q&A
Bonnie Hammer, Vice President of Biologics Development, Invenra, Inc discusses "The Impact of Biparatopic Antibodies on Immuno-Oncology"
Immuno UK PEN Carousel
Pre-Event Newsletter
Insight from the expert speakers and sponsors of the 2019 Event.
Immuno UK PER Carousel
Post-Event Report
Statistics, feedback, photos and more from the 4th Annual Advances in Immuno-Oncology Congress.

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Virtual Events

In-Person Events

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Brochure

Full details regarding the Immuno Series UK are available for download in the Conference Brochure

Read Now